Dr. Xia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1441 Eastlake Ave
Los Angeles, CA 90089- Is this information wrong?
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2011 - 2014
- Albert Einstein College of MedicineClass of 2011
- University of PennsylvaniaBA, Biology, Magna Cum Laude
Certifications & Licensure
- CA State Medical License 2017 - 2025
- CT State Medical License 2014 - 2020
- RI State Medical License 2017 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsReal world prognostic utility of platelet lymphocyte ratio and nutritional status in first-line immunotherapy response in stage IV non-small cell lung cancer.Madeline MacDonald, Darin Poei, Alexis Leyba, Raymond Diep, Krithika Chennapan, Christopher Leon, Bing Xia, Jorge J Nieva, Robert Hsu> ;Cancer Treatment and Research Communications. 2023 Jan 1
- Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer.Robert Hsu, Denaly Chen, Bing Xia, Rebecca Feldman, Wendy Cozen, Luis E Raez, Hossein Borghaei, Chul Kim, Misako Nagasaka, Hirva Mamdani, Ari M Vanderwalde, Gilberto L...> ;Frontiers in Oncology. 2023 Jan 1
- Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study.Connor Willis, Hillevi Bauer, Trang H Au, Jyothi Menon, Sudhir Unni, Dao Tran, Zachary Rivers, Wallace Akerley, Matthew B Schabath, Firas Badin, Ashley Sekhon, Malini ...> ;Oncotarget. 2022 Dec 6
- Join now to see all
Abstracts/Posters
- HER2 Amplification in EGFR Mutant NSCLC After Acquired Resistance to EGFR-directed TherapiesBing Xia, Anna Wurtz, Scott N. Gettinger, Roy S. Herbst, Anne C. Chiang, Mimi Wan, Jeffrey Sklar, Veronique Neumeister, Katerina A. Politi and Sarah B. Goldberg, ASCO Annual Meeting, Chicago, IL, 6/4/2016
- HER2 Amplification in EGFR Mutant NSCLC After Acquired Resistance to First and Second Generation EGFR-InhibitorsBing Xia, Anna Wurtz, Scott N. Gettinger, Roy S. Herbst, Anne C. Chiang, Mimi Wan, Jeffrey Sklar, Veronique Neumeister, Katerina A. Politi and Sarah B. Goldberg, International Association for the Study of Lung Cancer (IASLC) 16th Annual Targeted Therapies of Lung Cancer Meeting, Santa Monica, CA., 2/17/2016
- Effect of Primary Tumor Size in Patients with Metastatic Non-Small-Cell Lung Cancer (NSCLC)Bing Xia, Feng Gao, Ramaswamy Govindan, Damiel Morgensztern, ASCO Annual Meeting, Chicago, IL, 6/1/2013
- Join now to see all
Press Mentions
- OncLive® Hosts the Latest State of the Science Summit™ on Non-Small Cell Lung CancerApril 29th, 2019
Research History
- Oncology FellowResearch has focused on investigating biomarkers and novel treatment strategies in non-small cell lung cancer (NSCLC). Particular interest in evaluating mechanisms of resistance in EGFR mutant disease and therapies for brain metastasis.2014 - Present
Professional Memberships
- Member
- Member
- Member
Other Languages
- Chinese (Mandarin)
Hospital Affiliations
- USC Norris Comprehensive Cancer CenterLos Angeles, California
- Keck Hospital of USCLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: